{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:13:31Z","timestamp":1791414811244,"version":"4.3.3"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1684\/bdc.2011.1526","type":"journal-article","created":{"date-parts":[[2019,8,13]],"date-time":"2019-08-13T16:07:50Z","timestamp":1565712470000},"page":"7-12","source":"Crossref","is-referenced-by-count":25,"title":["Anatomopathologie des cancers de l\u2019endom\u00e8tre"],"prefix":"10.1016","volume":"99","author":[{"given":"Anne-Flore","family":"Albertini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mojgan","family":"Devouassoux-Shisheboran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Genestie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1684\/bdc.2011.1526_bib0005","unstructured":"INCA. Recommandations pratiques du cancer de l\u2019endom\u00e8tre, (Institut national du cancer) 2010."},{"key":"10.1684\/bdc.2011.1526_bib0010","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0090-8258(83)90111-7","article-title":"Two pathogenetic types of endometrial carcinoma","volume":"15","author":"Bokhman","year":"1983","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2011.1526_bib0015","first-page":"228","article-title":"A dualistic model for endometrial carcinogenesis based on immunohistochemical and molecular genetic analyses","volume":"81","author":"Lax","year":"1997","journal-title":"Verh Dtsch Ges Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/modpathol.3880051","article-title":"Theories of endometrial carcinogenesis: a multidisciplinary approach","volume":"13","author":"Sherman","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \u201cuntreated\u201d hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1684\/bdc.2011.1526_bib0030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1684\/bdc.2011.1526_bib0035","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1016\/S0140-6736(05)66431-8","article-title":"Hormones and endometrial cancer \u2013 new data from the Million Women Study","volume":"365","author":"Brinton","year":"2005","journal-title":"Lancet"},{"key":"10.1684\/bdc.2011.1526_bib0040","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1158\/1055-9965.EPI-05-0111","article-title":"Endometrial carcinoma risks among menopausal estrogen plus progestin and unopposed estrogen users in a cohort of postmenopausal women","volume":"14","author":"Lacey","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1684\/bdc.2011.1526_bib0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.anndiagpath.2008.02.004","article-title":"Histopathology of endometrial hyperplasia and endometrial carcinoma. An update by Dr LC Horn et al inAnnals of Diagnostic Pathology 2007 ; 11 : 297-311","volume":"12","author":"Zheng","year":"2008","journal-title":"Ann Diagn Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0050","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.maturitas.2009.02.005","article-title":"Endometrial hyperplasia and the risk of progression to carcinoma","volume":"63","author":"Lacey","year":"2009","journal-title":"Maturitas"},{"key":"10.1684\/bdc.2011.1526_bib0055","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/cncr.21650","article-title":"Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study","volume":"106","author":"Trimble","year":"2006","journal-title":"Cancer"},{"key":"10.1684\/bdc.2011.1526_bib0060","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.pgp.0000228138.56222.4e","article-title":"Occurrence of endometrial glandular dysplasia precedes uterine papillary serous carcinoma","volume":"26","author":"Zheng","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0065","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/0046-8177(95)90203-1","article-title":"Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation","volume":"26","author":"Ambros","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00000478-200006000-00004","article-title":"Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation","volume":"24","author":"Wheeler","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0075","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/modpathol.3800271","article-title":"Minimal uterine serous carcinoma: a clinicopathological study of 40 cases","volume":"18","author":"Hui","year":"2005","journal-title":"Mod Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0080","unstructured":"Tavassoli FADP. Pathology and genetics of tumours of breast and female genital organs. Edited by Tumors IWCO 2003."},{"key":"10.1684\/bdc.2011.1526_bib0085","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/GRF.0b013e3182185baa","article-title":"Revised FIGO staging system for endometrial cancer","volume":"54","author":"Lewin","year":"2011","journal-title":"Clin Obstet Gynecol"},{"key":"10.1684\/bdc.2011.1526_bib0090","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1684\/bdc.2011.1526_bib0095","first-page":"3254","article-title":"PTEN mutations and microsatellite instability in complex atypical hyperplasia, a precursor lesion to uterine endometrioid carcinoma","volume":"58","author":"Levine","year":"1998","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2011.1526_bib0100","first-page":"389","article-title":"PTEN-positive and phosphorylated-Akt-negative expression is a predictor of survival for patients with advanced endometrial carcinoma","volume":"14","author":"Uegaki","year":"2005","journal-title":"Oncol Rep"},{"key":"10.1684\/bdc.2011.1526_bib0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00441-005-0082-3","article-title":"PTEN is involved in the signal transduction pathway of contact inhibition in endometrial cells","volume":"323","author":"Uegaki","year":"2006","journal-title":"Cell Tissue Res"},{"key":"10.1684\/bdc.2011.1526_bib0110","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrd2062","article-title":"Current development of mTOR inhibitors as anticancer agents","volume":"5","author":"Faivre","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1684\/bdc.2011.1526_bib0115","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/modpathol.2009.5","article-title":"Concomitant PI3K-AT and p53 alterations in endometrial carcinomas are associated with poor prognosis","volume":"22","author":"Catasus","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0120","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/jnci\/92.11.924","article-title":"Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers","volume":"7","author":"Mutter","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1684\/bdc.2011.1526_bib0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/modpathol.3800992","article-title":"PIK3CA mutations in the kinase domain (exon 20) of uterine endometrial adenocarcinomas are associated with adverse prognostic parameters","volume":"21","author":"Catasus","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0130","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1158\/1078-0432.CCR-06-1375","article-title":"PIK3CA and PTEN mutations in uterine endometrioid carcinoma and complex atypical hyperplasia","volume":"12","author":"Hayes","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1684\/bdc.2011.1526_bib0135","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1158\/0008-5472.CAN-08-0755","article-title":"PIK3CA cooperates with other phosphatidylinositol 3\u2019-kinase pathway mutations to effect oncogenic transformation","volume":"68","author":"Oda","year":"2008","journal-title":"Cancer Res"},{"key":"10.1684\/bdc.2011.1526_bib0140","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1053\/hupa.2002.30723","article-title":"CTNNB1 mutations and beta-catenin expression in endometrial carcinomas","volume":"33","author":"Machin","year":"2002","journal-title":"Hum Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0145","doi-asserted-by":"crossref","first-page":"7981","DOI":"10.1038\/sj.onc.1205924","article-title":"Abnormalities of the APC\/beta-catenin pathway in endometrial cancer","volume":"21","author":"Moreno-Bueno","year":"2002","journal-title":"Oncogene"},{"key":"10.1684\/bdc.2011.1526_bib0150","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1038\/modpathol.3880196","article-title":"Mutational analysis of the CTNNB1 and APC genes in uterine endometrioid carcinoma","volume":"13","author":"Schlosshauer","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0155","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1097\/PGP.0b013e31818d8fe6","article-title":"DNA mismatch repair deficiency in endometrial carcinoma","volume":"28","author":"Karamurzin","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0160","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/BF02586773","article-title":"The cancer-family syndrome: a pragmatic basis for syndrome identification","volume":"22","author":"Lynch","year":"1979","journal-title":"Dis Clon Rectum"},{"key":"10.1684\/bdc.2011.1526_bib0165","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1001\/jama.2011.743","article-title":"Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.","volume":"305","author":"Bonadona","year":"2011","journal-title":"JAMA"},{"key":"10.1684\/bdc.2011.1526_bib0170","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/01.pas.0000213428.61374.06","article-title":"Utility of immunohistochemistry in predicting microsatellite instability in endometrial carcinoma","volume":"31","author":"Modica","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0175","first-page":"162363","article-title":"Molecular profiling of endometrial malignancies","author":"Sarmarnthai","year":"2010","journal-title":"Obstet Gynecol Int"},{"key":"10.1684\/bdc.2011.1526_bib0180","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1028-4559(08)60102-3","article-title":"Molecular carcinogenesis of endometrial cancer","volume":"46","author":"Liu","year":"2007","journal-title":"Taiwan J Obstet Gynecol"},{"key":"10.1684\/bdc.2011.1526_bib0185","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/0046-8177(95)90204-X","article-title":"p53 in endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis","volume":"26","author":"Sherman","year":"1995","journal-title":"Hum Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0190","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1006\/gyno.1994.1092","article-title":"Expression of EGFR, HER-2\/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas","volume":"53","author":"Khalifa","year":"1994","journal-title":"Gynecol Oncol"},{"key":"10.1684\/bdc.2011.1526_bib0195","first-page":"153","article-title":"Loss of nuclear p16 protein expression is not associated with promoter methylation but defines a subgroup of aggressive endometrial carcinomas with poor prognosis","volume":"6","author":"Salvesen","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1684\/bdc.2011.1526_bib0200","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1200\/JCO.2005.03.4827","article-title":"HER-2 is an independent prognostic factor in endometrial cancer: association with outcome in a large cohort of surgically staged patients","volume":"24","author":"Morrison","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1684\/bdc.2011.1526_bib0205","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bjc.6604814","article-title":"HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer","volume":"100","author":"Konecny","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1684\/bdc.2011.1526_bib0210","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/PAS.0b013e3181483ff8","article-title":"The oncofetal protein IMP3: a novel biomarker for endometrial serous carcinoma","volume":"32","author":"Zheng","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1684\/bdc.2011.1526_bib0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/annonc\/mdp120","article-title":"Endometrial carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20 Suppl 4","author":"Baekelandt","year":"2009","journal-title":"Ann Oncol"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115305063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455115305063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T04:35:03Z","timestamp":1602477303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455115305063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0007455115305063"],"URL":"https:\/\/doi.org\/10.1684\/bdc.2011.1526","relation":{"is-cited-by":[{"id-type":"doi","id":"10.5812\/ijcp.5285","asserted-by":"object"}]},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]}}}